JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.
7 Analysts Have This to Say About CymaBay Therapeutics
Over the past 3 months, 7 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts…